Silence Therapeutics

Silence Therapeutics

Silence Therapeutics

We are a leader in the development & delivery of RNA therapeutics for the modulation of gene expression up as well as down. Publicly Listed, AIM:SLN.
Founded
1999
Raised
$58.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$58,200,000
Venture capital - 2015
Team Size
10+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Silence Therapeutics makes some noise.